Todd C. Brady, President and CEO at Aldeyra Therapeutics, Inc. (ALDX), bought 28,576 shares at $5.91 ($169K) on 2019-09-18, disclosed to the SEC on 2019-09-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.91 | 14,288 | $84K | 50.0% |
| 2 | $5.91 | 14,288 | $84K | 50.0% |
| Total | $5.91 avg | 28,576 | $169K | 100% |
| Filing → |
| ALDX | BUY | 2022-06-27 | $59K | — | Filing → |
| ALDX | BUY | 2019-12-18 | $102K | — | Filing → |
| ALDX | BUY | 2019-10-02 | $49K | — | Filing → |